Targeted therapies in CLL. New drugs against CLL recurrent mutations 

Giménez Carabaza, Neus (Date of defense: 2019-11-15)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western countries. It is currently an incurable disease. CLL is a B-lymphoid neoplasm in which the microenvironment plays a key role in the development ...